Literature DB >> 31369701

Novel functions of inactive rhomboid proteins in immunity and disease.

Ramasatyaveni Geesala1,2, Priya D Issuree1,2, Thorsten Maretzky1,2,3.   

Abstract

iRhoms are related to a family of intramembrane serine proteinases called rhomboids but lack proteolytic activity. In mammals, there are two iRhoms, iRhom1 and iRhom2, which have similar domain structures and overlapping specificities as well as distinctive functions. These catalytically inactive rhomboids are essential regulators for the maturation and trafficking of the disintegrin metalloprotease ADAM17 from the endoplasmic reticulum to the cell surface, and are required for the cleavage and release of a variety of membrane-associated proteins, including the IL-6 receptor, l-selectin, TNF, and EGFR ligands. iRhom2-dependent regulation of ADAM17 function has been recently implicated in the development and progression of several autoimmune diseases including rheumatoid arthritis, lupus nephritis, as well as hemophilic arthropathy. In this review, we discuss our current understanding of iRhom biology, their implications in autoimmune pathologies, and their potential as therapeutic targets. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  a disintegrin and metalloprotease 17 (ADAM17); epidermal growth factor receptor (EGFR); inactive rhomboid 1 (iRHOM1); inactive rhomboid 2 (iRHOM2); rhomboid 5 homolog 1 (RHBDF1); rhomboid 5 homolog 2 (RHBDF2); tumor necrosis factor (TNF)

Mesh:

Substances:

Year:  2019        PMID: 31369701     DOI: 10.1002/JLB.3VMR0219-069R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  KOMPEITO, an Atypical Arabidopsis Rhomboid-Related Gene, Is Required for Callose Accumulation and Pollen Wall Development.

Authors:  Masahiro M Kanaoka; Kentaro K Shimizu; Bo Xie; Sinisa Urban; Matthew Freeman; Zonglie Hong; Kiyotaka Okada
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

2.  Deficiency of inactive rhomboid protein 2 (iRhom2) attenuates diet-induced hyperlipidaemia and early atherogenesis.

Authors:  Carmen Hannemann; Johannes H Schecker; Alica Brettschneider; Jana Grune; Nicole Rösener; Andrea Weller; Verena Stangl; Edward A Fisher; Karl Stangl; Antje Ludwig; Bernd Hewing
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

Review 3.  The Role of iRhom2 in Metabolic and Cardiovascular-Related Disorders.

Authors:  Ramasatyaveni Geesala; Priya D Issuree; Thorsten Maretzky
Journal:  Front Cardiovasc Med       Date:  2020-11-24

4.  Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver disease.

Authors:  Rong Gao; Jin Wang; Xuemin He; Tongtong Wang; Li Zhou; Zhitao Ren; Jifeng Yang; Xiaoxin Xiang; Shiyi Wen; Zhuojun Yu; Heying Ai; Yuchan Wang; Hua Liang; Shasha Li; Yan Lu; Yanhua Zhu; Guojun Shi; Yanming Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-12       Impact factor: 6.055

Review 5.  Regulation of ADAM10 by the TspanC8 Family of Tetraspanins and Their Therapeutic Potential.

Authors:  Neale Harrison; Chek Ziu Koo; Michael G Tomlinson
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 6.  iRhom2: An Emerging Adaptor Regulating Immunity and Disease.

Authors:  Mazin A Al-Salihi; Philipp A Lang
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.